RxDoctor Payments Data

Roy Ashton, DPM

Foot Surgery · Dallas, TXNPI 1821147091

Payments from drug & device makers

What this record shows

12 manufacturers reported payments, led by DJO, LLC at 30.9% of the total. Reporting peaked in 2023 at $259 and has fallen 82.5% since, to $45 in 2025. That places this record below the midpoint for foot surgery clinicians in TX, where the typical reported total is $2,095.

$707in general payments, 2019–2025

Across 23 payments — averaging $30.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • DJO, LLC$218
  • Rikco International, LLC$93
  • Sandoz$83
  • IBSA Pharma Inc.$78
  • Integra Lifesciences Corporation$49
  • Amgen$47
  • plus $138 from 6 others

What the payments were for

  • Food & beverage$39656%
  • Education$31144%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
DJO, LLC2$218
Rikco International, LLC2$93
Sandoz4$83
IBSA Pharma Inc.3$78
Integra Lifesciences Corporation2$49
Amgen3$47
Journey Medical Corporation2$45
Treace Medical Concepts, Inc.1$24
Pylant Medical1$21
Zyla Life Sciences, Inc.1$17
Alfasigma USA, Inc.1$15
Sebela Pharmaceuticals Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$707 in reported general payments places this provider in the 25th percentile of 71 foot surgery providers in Texas.

See all foot surgery providers in Texas

Medicare billing

Part B allowed, 2024
$193,933
Medicare patients
514
Services billed
2,893

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate26$1,224
CiclopiroxCiclopirox Olamine42$1,009
Gabapentin87$813
Allopurinol56$717
Terbinafine Hcl90$655
Meloxicam188$540
Mupirocin67$526
Ciclopirox11$499
Doxycycline Hyclate27$405
Celecoxib19$387
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$218
Methylprednisolone22$124
Cephalexin14$102
Levofloxacin12$94
Acetaminophen-CodeineAcetaminophen With Codeine13$75

Paid to pharmacies, not to this prescriber.

Other foot surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →